CFMG & Wellpath in California — a documentary investigation · Article 016 of 100 · Series 2 — Inside the management agreement

The 18 Percent Question: What the Management Fee Says About Economic Integration

Published

20 September 2026, 6:00 PM PT

Content last changed

20 September 2026, 6:00 PM PT

Public-evidence cutoff

20 September 2026, 6:00 PM PT

Sources checked

20 September 2026, 6:00 PM PT

Record through

20 September 2026, 6:00 PM PT

Editorial status

Public-source editorial review complete

Evidence note. This article relies on public records and distinguishes established fact, party position, allegation, judicial finding, inference and unresolved question. Nothing here is a finding that any identified corporation or individual violated California law unless a cited adjudicative source expressly says so.

Opening frame#

The 18 Percent Question: What the Management Fee Says About Economic Integration turns on the difference between authority written on paper and authority demonstrated in operation. The analysis reads the management-services architecture as a division of functions, then tests whether the economic and administrative structure supports, constrains, or leaves unanswered the professional authority formally reserved to CFMG.

The governing question is narrow: How did the revenue-based management fee align the economics of PC and MSO? The article connects that question to juridical identity, operational integration, professional authority, ownership and succession, practical exit rights, and demonstrated veto power only where the evidence makes those connections material.

I. The Question and the Public Record#

The relevant public record is best read cumulatively. No single branding statement, county agenda item, corporate filing, bankruptcy disclosure, or management agreement resolves the entire relationship. The evidentiary value comes from comparing documents created for different purposes and asking whether they converge on the same allocation of identity, authority, economics, and professional responsibility.

THE CENTRAL QUESTION IS NO LONGER “WHO IS CFMG?”#

The first four volumes establish several propositions with substantial support:

• California Forensic Medical Group, Inc. (“CFMG”) remained a legally distinct California professional corporation after the rise of Wellpath.

• Wellpath and its predecessor management companies supplied extensive management infrastructure to CFMG.

• Counties, employees, unions, litigants, courts, and sometimes the companies themselves have used terminology that blurred the CFMG–Wellpath distinction.

• Bankruptcy forced substantially greater precision about legal identity.

• The public record still does not contain a judicial determination that the entire CFMG–Wellpath PC–MSO arrangement violates California’s prohibition on the corporate practice of medicine.

The next question is therefore more concrete:

When a decision had to be made, who actually possessed the authority to make it?

That question must be answered separately for physician employment, compensation, workload, scheduling, patient prioritization, referrals, diagnostics, utilization management, clinical policies, records, EHR access, equipment, credentialing, quality assurance, peer review, leave/reinstatement, discipline, and termination.

An MSO can perform extensive administrative work without practicing medicine. The key is where administrative support ends and professional authority begins.

II. Structural and Historical Context#

III. The Control and Governance Analysis#

Hiring and firing are also function-specific#

The Board’s guidance does not say every ordinary employment action involving a physician is necessarily the practice of medicine.

Its formulation focuses on selection, hiring and firing as related to clinical competency or proficiency .

That means an investigation of physician employment must ask why a decision was made.

A routine employment issue and a decision that a physician lacks clinical competence present different professional-control questions.

Layer one: explicit professional independence#

The agreement begins with formal safeguards.

It describes the parties as independent contractors. It says CFMG is solely and exclusively in control of professional medical services and says the management company will not control the methods by which physicians practice medicine.

It also states that the manager will not provide a service that would itself constitute clinical practice or professional medical services.

Those provisions are substantial evidence of the intended legal allocation .

They should not be dismissed merely because the same contract contains extensive management powers.

At the same time, formal language is not proof of how every later decision actually operated.

That distinction — intended allocation versus actual practice — is the central theme of this investigation.

Layer seven: finance and cash management#

The agreement also creates substantial financial integration.

The management-services package includes:

• accounting;

• financial reporting;

• invoicing;

• payroll/tax support;

• budgeting;

• cash management;

• benefit and bonus-plan administration.

Exhibit D provides for a management fee calculated as a percentage of adjusted gross revenues — identified in the filed version as 18% — and states that the parties regarded the fee as fair-market-value compensation for management services.

The same exhibit authorizes specified disbursement mechanics and grants the management company a security interest in CFMG assets to the extent permitted by law, with references to broader credit arrangements.

These are economically important provisions.

They are not, by themselves, proof of professional control.

But they make separate questions worth investigating:

• How economically dependent was CFMG on the management structure?

• What happened if the management agreement ended?

• What did the referenced deficit-funding and credit documents provide?

• Could financial remedies affect the practical ability to change managers?

Those questions require the related contracts, not inference from the MSA alone.

Layer nine: insurance, risk, claims and litigation#

The management agreement assigns the manager a role in obtaining or maintaining insurance, risk-management support, and assistance in responding to demands, liability allegations and lawsuits.

That means litigation infrastructure is part of the management architecture.

But claims administration is not automatically the same thing as:

• physician employment authority;

• corporate ownership;

• or clinical control.

This investigation will treat claims and defense as their own authority domain.

Master reader orientation#

The final project conclusion is not that CFMG and Wellpath are “the same entity,” nor that they are operational strangers.

The record supports a layered model:

• CFMG — legally distinct California professional corporation; formal County contractor and strong formal physician-employer evidence; claimed physician-governance authority.

• Wellpath / management entities — extensive MSO/enterprise infrastructure across HR, systems, compensation, credentialing administration, finance, claims, records, litigation, and other operational domains.

• County/client authority — an independent source of contract, security, access, transportation, remedial-plan, and operational requirements.

• Individual licensed clinicians — patient-specific professional judgment and other physician-reserved functions.

The final unresolved issue is function-specific:

When an administrative process reached a decision California reserves to physicians, who possessed practical final approval or veto, and what happened when CFMG and Wellpath disagreed?

National vertical management model — research hypothesis#

A recurring feature of the Wellpath model is national vertical management. Public corporate materials describe a large multi-state enterprise headquartered in Tennessee. Operational records and employment communications in the public record indicate that California functions were frequently administered through Wellpath executives, HR personnel, legal/risk personnel, and clinical leadership outside the local county facilities.

The relevant issue is not geography. A physician executive may lawfully supervise clinicians from another state, and an MSO may lawfully centralize administrative services. The relevant issue is authority .

the record should test the following hypothesis:

CFMG physicians may have held formal professional-corporation offices while substantial day-to-day operational authority flowed vertically through Wellpath's national or regional chain of command, with local jail physicians and healthcare staff reporting through Wellpath-managed operational structures.

This hypothesis must be tested county by county and function by function.

The evidence required includes:

• organizational charts by year;

• reporting lines for physicians, nursing, mental health, pharmacy, and dental services;

• job descriptions for HSA, DON, site medical director, regional medical director, state medical director, chief medical officer, and operations executives;

• authority matrices;

• policy approval metadata;

• EHR access-control records;

• compensation approval chains;

• disciplinary/termination workflows;

• county-facing escalation protocols;

• CFMG board minutes showing actual physician deliberation.

THE OVERRIDE TEST#

The most probative evidence of genuine physician independence may be actual conflict outcomes .

For each protected area, the record should look for instances where Wellpath and CFMG did not initially agree.

Then ask:

• Who proposed the action?

• Who objected?

• Who had formal approval rights?

• Who had practical veto rights?

• Whose position ultimately prevailed?

• Was the result documented as a CFMG physician decision?

• Could Wellpath implement the opposite result anyway?

Examples of highly probative records:

• CFMG physician rejects Wellpath HR termination recommendation;

• CFMG medical director refuses operations-imposed patient quota;

• CFMG physician approves referral after Wellpath administrative denial;

• CFMG board changes compensation model proposed by MSO;

• CFMG shareholder refuses proposed policy;

• Wellpath cannot replace or discipline physician decision-maker.

A lawful structure should produce at least some observable evidence of independent exercise of authority, especially over many years and many counties.

Absence of such records would not by itself prove sham governance, but it would increase the importance of the contractual control mechanisms.

Current event coding#

Chapman termination: Level 2–3. Wellpath participation is sworn; CFMG final approval unclear.

Fresno physician workload concerns: Level 1–2 based on contemporaneous firsthand record; independent verification needed.

Utilization management: Level 2 by Wellpath’s public statement and MSA; patient-specific final authority unknown.

Quality/mortality review: CFMG authority evidence Level 2–3; committee governance still needed.

Physician compensation: strong contractual authority language; event proof Level 1–2 until actual compensation decisions are traced.

EHR/records: technical authority Level 2–3; professional-content authority unresolved.

Strongest evidence justifying further control investigation#

Conversely, several facts justify deeper investigation:

• The MSO is CFMG’s exclusive management-services provider.

• A management representative can attend and participate in CFMG equityholder/governance meetings, though without vote.

• CFMG physician employment forms are prepared by management and cannot be amended without management approval.

• The MSA assigns extensive physician HR functions to management.

• The MSA says management will determine physician base and incentive compensation .

• Management participates in staffing deliberations and schedule review.

• Wellpath publicly says it provides CFMG utilization-management functions.

• Management administers EMR systems and supervises storage/maintenance of patient records.

• Management negotiates client agreements and professional-service agreements on CFMG’s behalf.

• Management acquires/holds title to substantial equipment and recommends medical equipment.

• CFMG designated a Wellpath HR executive as Rule 30(b)(6) PMK about a CFMG physician termination.

• That witness testified the physician was terminated by management working for Wellpath.

• The Wellpath enterprise handbook is broad enough on its face to include entities managed by Wellpath LLC, while its exact application to CFMG physicians remains unresolved.

• Contemporaneous California operating records show Wellpath HR, clinical leadership, insurance, claims, and enterprise systems interacting directly with CFMG physician matters.

• The 2019 assignment transferred the MSA together with related stock-transfer restriction agreements into the Wellpath structure.

These facts do not establish illegality. They establish why approval and override evidence is essential.

Cfmg's termination rights are real, but narrowly structured#

Section 5.2 permits CFMG to terminate immediately if the management company materially breaches the MSA, fails to cure within 45 days after written notice, and the breach materially adversely affects CFMG.

The required notice must be executed by the Company Designee to be effective.

CFMG can also terminate if the management company enters specified insolvency proceedings.

This is meaningful termination authority.

It is evidence against an assertion that CFMG had literally no contractual exit right.

But several structural features narrow that freedom.

First, the agreement does not appear to provide CFMG a broad termination-for-convenience right during the term.

Second, CFMG's breach notice must come from the Company Designee.

Third, the management company has its own termination rights.

Fourth, termination of the Deficit Funding Loan Agreement gives the management company an immediate termination right under the MSA.

Fifth, certain breaches can trigger substantial payment consequences.

Accordingly, the proper question is not whether CFMG had some termination right.

It is:

Could the physician corporation realistically choose a new MSO simply because its physicians preferred a different manager?

On the current text, that proposition is not established.

Wellpath’s Chapter 11 case is the strongest natural experiment yet for testing the CFMG–Wellpath relationship.

The reason is straightforward.

Before bankruptcy, extensive operational integration could coexist with imprecise nomenclature because there was often little immediate reason for counties, clinicians, litigants, or courts to distinguish the professional corporation from the management enterprise with precision.

Bankruptcy changed that.

Once Wellpath entered Chapter 11:

• debtor and nondebtor status mattered;

• property of the estate mattered;

• executory-contract rights mattered;

• insurance and indemnity mattered;

• ownership and contract rights mattered;

• the identity of the professional corporations mattered;

• the ability to continue management relationships mattered;

• and the transition from H.I.G.-sponsored ownership to lender ownership mattered.

The bankruptcy record therefore forced Wellpath to explain its professional-corporation architecture in pleadings filed before a federal bankruptcy court.

The result is unusually revealing.

Wellpath’s own November 12, 2024 Professional Corporation Motion described the nationwide structure as a “friendly professional corporation” structure . The Debtors said the professional corporations were owned exclusively by licensed physicians affiliated with the Debtors , while the Debtors exercised certain control over the nonclinical business-management and administrative functions. At the same time, the Debtors disclosed that:

• the 18 professional corporations collectively generated more than $674 million in 2023 revenue “for the benefit of the Debtors” ;

• the Debtors and certain physician owners were parties to Stock Transfer Agreements restricting transfer of professional-corporation stock;

• those restrictions were intended not only to maintain state-law compliance and continuity of care but also to preserve the continuation of administrative services by the Debtors ;

• under those Stock Transfer Agreements, the Debtors had authority to ensure that the professional corporations remained duly licensed and qualified;

• in 2023 the Debtors remitted approximately $720 million to physician owners and vendors as professional-corporation operating costs;

• the Debtors collected certain professional-corporation receivables and deposited them into professional-corporation accounts;

• the Debtors considered the professional-corporation relationships indispensable to the success of their own reorganization.

Most strikingly, the same motion later said that the Debtors “maintain an interest in the Professional Corporations” and referred to revenue derived pursuant to the Debtors’ “ownership interests in the Professional Corporations.”

That latter language is facially difficult to reconcile with the same pleading’s statement that the professional corporations were owned exclusively by licensed physicians .

this record does not treat that wording as proof that Wellpath owned CFMG stock.

The phrase may reflect:

• imprecise bankruptcy advocacy;

• an economic or contractual “interest” rather than stock ownership;

• differences among the 18 professional corporations;

• or drafting shorthand that did not carefully distinguish equity from contractual rights.

The court did not conduct a trial determining that Wellpath owned CFMG.

But the wording is too important to ignore.

It creates one of the strongest internal-document contradictions found in this investigation and sharply increases the importance of the actual CFMG stock-transfer agreements.

Why the stock-transfer document is different from the MSA#

The Management Services Agreement tells us who administers the business.

The stock-transfer agreement may tell us who ultimately controls the owner of the medical corporation.

That distinction is fundamental.

A lawful MSO can perform extensive administrative services for an independently controlled medical corporation.

Examples may include:

• payroll;

• accounting;

• IT;

• HR administration;

• insurance;

• procurement;

• billing;

• compliance support;

• scheduling support;

• records infrastructure;

• contracting support.

The physician corporation can remain substantively independent if the physician owners retain real authority over professional matters and meaningful governance power over the corporation.

A stock-transfer instrument becomes more consequential because it can affect the person who holds the legal voting stock.

If the MSO merely prevents an unqualified person from inheriting professional-corporation stock and provides an orderly mechanism for transfer to another independently selected qualified physician, the agreement may function as a legitimate compliance and continuity device.

If, by contrast, the MSO can decide who owns the PC, replace the owner at will, or cause the owner to lose stock for challenging the MSO, then the agreement can give the MSO leverage over every decision formally assigned to the physician owner.

The legal inquiry therefore changes from:

“Who performs management services?”

to:

“Who can remove the person who is supposed to control the professional corporation?”

The 2012 management-agreement baseline#

Earlier articles in this series identified the December 31, 2012 Management Services Agreement as the central structural instrument in the modern CFMG–MSO arrangement.

The reviewed project record attributes to that agreement several provisions favoring a lawful PC–MSO architecture:

• CFMG and the management organization are described as separate entities;

• CFMG formally employs or engages physicians;

• professional medical services and medical judgment are reserved to CFMG;

• the management organization is not itself to practice medicine or assume direct patient-care responsibility;

• broad administrative services are delegated to the management side.

The same record describes the management organization as having extensive responsibilities concerning:

• payroll and benefits administration;

• physician-employment documentation;

• HR support;

• staffing analysis;

• compensation administration and recommendations;

• billing and coding support;

• IT and electronic-record systems;

• insurance and risk;

• litigation support;

• contracting;

• purchasing and equipment;

• finance, banking, and budgeting;

• and participation in governance-related processes.

A project submission that reviewed the executed agreement also identifies a potentially important “Company Designee” mechanism, under which certain CFMG actions or approvals may be communicated through a designated CFMG officer or designee and relied upon by the management organization as CFMG action.

That mechanism is not inherently improper. But it makes authentication of the approval chain essential. If CFMG decisions were routinely transmitted through one designee, the investigation must know:

• who held that role at each relevant time;

• whether the designee was a licensed physician;

• what authority had been delegated;

• whether professional decisions could be delegated at all;

• what record showed the underlying physician decision;

• and whether the MSO could act without obtaining a fresh CFMG approval.

The MSA therefore provides the formal hypothesis. the prior analysis tests whether actual conduct matched it.

Evidentiary caution: the standalone executed 2012 MSA has not yet been separately indexed in the current saved Library under an obvious filename. the investigation's existing section-by-section crosswalk should be treated as a strong retrieval guide, while the executed agreement, exhibits, assignments, amendments, and designee records remain Tier-One authentication targets.

Medical director authority — title is not enough#

The term “Medical Director” can conceal several legally different roles.

A physician may be:

• a site medical director for the Fresno County jail;

• a regional medical director;

• a national Wellpath physician executive;

• a CFMG officer or director;

• an MSO-employed physician providing management services;

• a member of a CFMG physician board;

• a credentialing or quality reviewer;

• or some combination of those roles.

the investigation must therefore stop treating “medical director” as a self-executing answer to control.

For every physician leader involved in a disputed event, the record should identify:

• employing entity;

• corporate office, if any;

• California license status;

• written appointment;

• written delegation;

• reporting line;

• scope of clinical authority;

• scope of HR authority;

• authority to bind CFMG;

• authority to approve or reject Wellpath recommendations;

• authority over privileging/credentialing;

• authority over peer review and section 805 reporting;

• authority over physician schedules and patient volume;

• authority over referral/utilization disputes;

• and evidence of actual exercise of those powers.

Dr. Dheeraj Taranath's April 2025 communication is especially relevant. He described Wellpath as the management services organization contracted to provide the “full range of administrative services” to CFMG and represented that matters raised by the physician had been reviewed with CFMG leadership and that Wellpath communications proceeded with CFMG leadership's knowledge and approval.

That communication supports two competing inferences.

Defense inference: Wellpath was operating as an MSO and took recommendations to CFMG leadership, which retained approval.

Investigative inference: Wellpath may have functioned as the practical decision engine, with CFMG leadership providing approval after recommendations had already been developed.

The distinction cannot be resolved from phrasing alone. The underlying approval records are needed.

Why an override census is more probative than a control narrative#

The phrase “who controlled CFMG?” is too broad to be useful without identifying the function, time, site, and decision.

A professional corporation can lawfully delegate or outsource administrative implementation while retaining protected professional authority. A management organization can also influence outcomes without formally owning the professional decision. The only reliable way to distinguish the two is to reconstruct concrete events.

For each event the record now asks:

• What triggered the decision?

• Who opened the workflow?

• Who developed the factual record?

• Who recommended an outcome?

• Was a professional review required?

• Which licensed physician or physician body performed that review?

• Could that reviewer reject the recommendation?

• Did the reviewer ever ask questions, delay action, impose conditions, modify reasoning, dissent, or say no?

• Who entered the final decision into the operational system?

• Did implementation occur before or after professional approval?

• What happened when the professional and administrative participants disagreed?

The last question is the most valuable.

If Wellpath recommends termination and a CFMG physician body rejects termination, and the physician remains employed, the event strongly supports practical CFMG veto power. If Wellpath proposes a workload target and a CFMG medical director reduces it for safety reasons, and the reduced target governs despite financial cost, that is strong evidence of professional independence. If a Wellpath utilization mechanism initially denies an outside referral and a CFMG physician reverses the denial, that can show physician authority over patient-specific care.

The reverse matters too. If a CFMG physician rejects an administrative recommendation but Wellpath proceeds anyway, or if Wellpath implements a clinically sensitive action before any CFMG physician review, that would weigh in the opposite direction.

Routine concurrence has much less discriminatory value. A physician can agree with an MSO recommendation for legitimate reasons. A long series of unanimous decisions proves little unless the record also shows that disagreement was practically possible.

A. Core defense narrative#

CFMG is a California professional medical corporation that remained legally distinct from Wellpath and formally employed physicians. Wellpath and predecessor management entities supplied the extensive administrative infrastructure that allows a statewide correctional medical practice to function: payroll, benefits, HR support, information technology, credentialing administration, contracting support, insurance/risk, claims, litigation support, purchasing, finance, and related services.

The 2012 Management Services Agreement was deliberately structured to reserve professional medical services and physician judgment to CFMG while prohibiting the manager from practicing medicine or directly assuming patient-care responsibility. The management company was not pretending to be a hospital or a medical group. It was an MSO.

The fact that administrative functions became highly centralized after the 2018 Wellpath merger does not convert the MSO into the medical corporation.

The best direct evidence for that proposition includes:

• CFMG's continued separate legal existence;

• post-bankruptcy stipulations and orders treating CFMG as separate from Wellpath;

• quarterly DE 9 and DE 9C wage reports identifying the reporting entity, which would establish the same proposition from a public filing — not located in the public record for this project;

• sworn testimony that CFMG pays its employees;

• the Fresno County contract structure;

• contemporaneous professional-employment decision records showing which entity exercised the authority — not located in the public record for this project;

• and the unresolved public question of how CFMG physician-governance bodies are constituted, delegated, and documented in practice.

The defense therefore says:

the investigation has proved administrative integration, not unlawful displacement of physician authority.

December 31, 2012 — Management Services Agreement#

The executed MSA is the structural baseline.

It contains substantial provisions favoring legality:

• independent-entity framing;

• CFMG employment/engagement of physicians;

• reservation of professional medical services and medical judgment;

• prohibition on manager practice of medicine.

It also creates unusually broad administrative integration:

• finance;

• accounting;

• payroll;

• tax;

• benefits;

• HR;

• staffing analysis;

• physician compensation administration;

• billing/coding support;

• IT;

• EHR/records infrastructure;

• contracting support;

• compliance;

• insurance/risk;

• litigation;

• purchasing/equipment;

• banking/budgeting;

• governance-adjacent participation.

The MSA therefore proves neither unlawful control nor operational independence by itself.

IV. Contrary Evidence, Limits, and Competing Explanations#

A disciplined analysis must begin its limiting case with the strongest contrary evidence: The strongest contrary evidence is the MSA's explicit reservation of professional authority and real termination rights. The article must distinguish structural leverage from proof of an actual unlawful medical decision.

The most important development from this analysis is not another malpractice case. It is a pattern of formal identity descriptions that change depending on the legal or institutional context .

Across the period reviewed, the relationship has been described in at least the following ways:

• CFMG as the California professional corporation and Wellpath as its management-services organization;

• CFMG “dba Wellpath” in county contracting records;

• CFMG and Wellpath as “for all intents and purposes” the same entity for purposes of particular litigation and discovery;

• Wellpath and CFMG as having effectively the same recordkeeping, employees, and other functions for discovery purposes;

• CFMG as “separate and distinct” from Wellpath after bankruptcy forced the parties to identify the correct non-debtor California entity;

• CFMG as a “subsidiary company of Wellpath Management Inc.” in a post-bankruptcy Tulare stipulation based on advice reportedly received from bankruptcy counsel;

• CFMG as a “corporate parent” of Wellpath LLC in several Northern District of California interested-entity disclosures;

• CFMG as an “other affiliate” of Wellpath in another federal disclosure;

• Wellpath LLC as an “other affiliate” of CFMG in a 2026 disclosure;

• CFMG as the formal employer in NLRB proceedings while unions and public-facing labor communications identify the workforce as Wellpath workers;

• CFMG as the county contractor while Wellpath is expressly identified by counties as the MSO providing payroll, HR, risk, litigation support, accounting, licensing, and related infrastructure.

These descriptions cannot simply be stacked together as proof that one of them is false. Different legal questions legitimately produce different descriptions. A professional corporation may be a separate juridical entity, use a common brand, outsource extensive administrative functions, participate in a consolidated insurance program, and still remain the lawful physician-controlled medical corporation.

What makes this record important is the repeated difficulty of identifying where formal CFMG authority ends and Wellpath authority begins . That difficulty appears not only in plaintiff pleadings, but in government procurement records, labor records, defense stipulations, bankruptcy papers, corporate-disclosure filings, and the companies’ own operating materials.

This article therefore adopts an additional research rule:

Identity labels are evidence of how the relationship was represented, not proof of how authority was actually allocated.

The final CPOM analysis must turn on decision rights and decision practice , not nomenclature.

V. Missing Documents and Falsification Tests#

The record remains incomplete in material respects. Key unresolved points include Company Designee history, practical MSO replacement, compensation veto, and an actual event where formal professional authority changed management's preferred outcome.

2013: H.I.G. announces an investment#

On January 7, 2013, H.I.G. Capital announced that an affiliate had made a strategic investment in CFMG. H.I.G. described the transaction as a partnership with CFMG’s existing management team. H.I.G., 2013

The wording is important.

The public announcement supports an investment relationship. It does not, without the underlying stock records, establish exactly what entity H.I.G. acquired or whether a non-physician investor ever held CFMG professional-corporation shares.

That distinction should remain explicit throughout this investigation.

Layer ten: management fee, credit and collateral#

The filed agreement refers to:

• the management fee;

• a Deficit Funding Loan Agreement;

• broader credit relationships;

• and a security interest in company assets to the extent permitted by law.

The underlying financial documents are important because they may show the practical economic relationship between CFMG and the manager.

The MSA alone does not establish whether those mechanisms were ordinary commercial protections or whether they materially constrained CFMG’s ability to operate independently.

That is an open-document question.

The next evidentiary step#

The management agreement gives the investigation a roadmap.

The next phase is to look for public “natural experiments” — situations where:

• management recommended one result;

• physician authority wanted another;

• and one side’s decision controlled implementation.

That kind of disagreement evidence is more informative than another hundred examples of routine cooperation.

The central question remains:

Who could say no — and did the other side have to listen?

Current evidence supporting deeper structural-control investigation#

The strongest contrary or investigative facts include:

• Wellpath/MSO is the exclusive manager.

• The original term was ten years, with five-year automatic renewals.

• CFMG lacks an obvious broad termination-for-convenience right in the public MSA.

• Management receives notice of and can participate in all covered CFMG shareholder/Company Designee meetings.

• Failure to provide required meeting notice can support manager termination.

• CFMG action can be concentrated through one Company Designee.

• CFMG cannot assign the MSA without manager consent.

• Manager can freely assign without CFMG consent.

• The 2019 assignment transferred related stock-transfer restriction agreements.

• Management fee begins at 18% of adjusted gross revenue.

• Manager may cause disbursement from CFMG accounts, including advances before due date.

• CFMG grants a broad security interest in its assets to secure amounts owed.

• CFMG may be financially dependent on manager advances under the Deficit Funding Loan Agreement.

• Manager may terminate the MSA when the Deficit Funding Loan Agreement terminates.

• Certain termination scenarios accelerate management fees for the remainder of the term.

• Personnel restrictions may affect CFMG's ability to recreate management infrastructure after exit.

• Manager-side financing links the CFMG payment stream to collateral-agent arrangements.

• Current stock-transfer/succession instruments remain undisclosed in the public corpus.

These facts still do not establish unlawful control.

They establish why the missing instruments have unusually high evidentiary value.

The MSA also contains structural features that increase the importance of the stock agreement#

The same MSA includes features discussed earlier in this series:

• exclusive manager;

• long initial term;

• automatic renewals;

• management participation in shareholder/Company-Designee meetings;

• manager preparation/control of physician agreement forms;

• physician-compensation authority language;

• broad management infrastructure;

• asymmetric assignment rights;

• percentage-of-revenue management fee;

• cash-management authority;

• manager security interest;

• deficit funding;

• termination consequences.

None of these provisions alone proves unlawful control.

But if the stock agreement also gives Wellpath the power to replace the physician owner, the provisions no longer operate as isolated commercial terms.

They become part of a single control architecture .

That is why the actual stock agreement is decisive.

The “real disagreement” test remains the gold standard#

Even after the stock agreement is obtained, actual conduct will remain important.

The best evidence of real independence would be a documented disagreement in which:

• Wellpath wanted one result;

• the CFMG physician owner/board wanted another;

• the physician decision prevailed;

• and the physician did not lose employment, ownership, or corporate authority.

Examples could include:

• rejecting a termination recommendation;

• rejecting a patient-volume target;

• modifying compensation;

• approving a referral despite cost concerns;

• refusing an enterprise clinical policy;

• replacing an MSO executive liaison;

• withholding a management bonus.

The best evidence of capture would be the opposite:

• physician resists;

• Wellpath threatens/uses stock or employment rights;

• physician is replaced;

• decision changes.

This is why contract rights and real-world events must ultimately be paired.

VI. Why the Issue Matters#

The stakes are practical rather than semantic. Counties need to know which entity is accountable for contracted performance; clinicians need to know where professional authority resides; courts and regulators need entity-specific evidence rather than brand shorthand; and the public needs a record that distinguishes corporate continuity from operational integration. Those distinctions become most important when the actors disagree, when a contract changes hands, when a professional decision conflicts with an economic preference, or when litigation requires a precise answer to who had authority to act.

What the Medical Board says physicians must control#

The Medical Board of California’s current corporate-practice guidance makes the line unusually concrete.

The Board says the doctrine is intended to prevent unlicensed persons from interfering with or influencing professional judgment. It identifies several healthcare decisions that should be made by California-licensed physicians:

• appropriate diagnostic testing;

• referrals and specialist consultation;

• responsibility for the patient’s ultimate overall care and treatment options;

• how many patients a physician must see;

• how many hours a physician must work.

The Board then identifies additional “business” or “management” decisions that can amount to control of medical practice, including:

• control of medical records and their contents;

• physician and clinical-staff hiring or firing when clinical competency or proficiency is involved;

• parameters for payer relationships;

• coding and billing procedures;

• selection of medical equipment and supplies.

Medical Board of California — Practice Information

That list is crucial because it prevents two analytical mistakes.

VII. Falsification Tests and Evidentiary Limits Note#

The record does not support be read as establishing an unproven motive, an undisclosed shareholder, an unlawful medical override, or a legal conclusion that a court or regulator has not made. The strongest version of the thesis is the one that survives the missing-document test: identify the instrument, minutes, ledger, delegation, approval record, or disagreement event that would materially change the conclusion, then state what has and has not been found. If later primary evidence contradicts a proposition stated here, the correction should be made at the proposition level rather than defended through branding or organizational shorthand.

VIII. Related Articles#

• Article 015 — Physician Pay as a Control Boundary: Compensation Inside the CFMG–Wellpath MSA

• Article 017 — Deficit Funding, Security Interests, and the Economics of Saying No

• Article 014 — Who Designs the Physician Employment Contract? CFMG, Wellpath, and the Employment-Form Architecture

The proposition to be tested#

The central proposition in this article is not that every appearance of the Wellpath name proves control, nor that formal CFMG separateness ends the inquiry. The proposition to be tested is narrower: How did the revenue-based management fee align the economics of PC and MSO? A serious legal brief should state that proposition before discussing motive, liability, or remedy because the same document can be highly probative on one dimension and nearly irrelevant on another.

For this subject, the principal evidentiary dimensions are management fee, economic integration, fair-market services, and incentive alignment. The source spine identified in the current public record is: MSA fee provisions; finance exhibits; bankruptcy finance records; contrary evidence about legitimate MSO compensation. Those sources should not be pooled as though they were interchangeable. A county contract speaks most reliably to the county's counterparty and purchased obligations. A management agreement speaks to contractual allocation between the professional corporation and manager. A court order speaks to the matter actually adjudicated. A party filing or corporate announcement remains a representation unless independently adopted or found by a tribunal.

A management-services agreement must be read function by function. Administrative delegation is not synonymous with delegation of professional judgment. The evidentiary task is to identify the exact contractual reservation, the exact management power, and the real-world implementation record when those provisions came into tension. The practical advantage of that method is that it prevents a common failure in complex-enterprise investigations: using a true fact about one relationship as proof of a different relationship. A shared brand may show integration; a W-2 may show payroll identity; a contract signature may show authority to bind a corporation; an officer title may show corporate office. None automatically proves stock ownership or final clinical authority.

The charging or enforcement threshold, if any regulator ever considered one, would therefore require an evidence chain rather than a collage: identify the protected or regulated function; identify the actor with formal authority; reconstruct the first operative decision; identify the person or entity that could approve, reject, modify, or reverse it; and verify who implemented the result. Until that chain is complete, the proper classification is evidence, inference, or unresolved question—not adjudicated fact.

Weighing the evidence#

The evidentiary hierarchy for The 18 Percent Question: What the Management Fee Says About Economic Integration should begin with contemporaneous primary instruments and end with retrospective shorthand. Executed contracts, amendments, assignments, board resolutions, authenticated corporate records, court orders, government payroll or labor records, and formal agency records ordinarily deserve more weight on the proposition they were created to establish than marketing language or later summaries. Even among primary materials, however, purpose matters. A contract can establish contractual rights without proving that those rights were exercised; a tax record can establish reporting without deciding every common-law employer factor; a bankruptcy schedule can establish debtor treatment without answering professional-governance questions for a nondebtor corporation.

The article's existing record illustrates why that hierarchy matters.ntiary lane. The 18 Percent Question: What the Management Fee Says About Economic Integration turns on the difference between authority written on paper and authority demonstrated in operation. The analysis reads the management-services architecture as a division of functions, then tests whether the economic and administrative structure supports, constrains, or leaves unanswered the professional authority formally reserved to CFMG.

A prosecutor, defense lawyer, regulator, or investigative editor should ask five questions of every source: Who created it? What legal or business purpose did it serve? What date and entity does it concern? Is the statement a recital, operative term, allegation, stipulation, finding, or marketing representation? What independent record could confirm or contradict it? Applying those questions consistently is more valuable than multiplying citations that all derive from the same underlying assertion.

This also defines how contradictions should be handled. When two records use different labels, the first step is not to accuse one of being false. The first step is to determine whether the records were answering different questions. Only after normalizing entity, date, capacity, forum, and purpose should a remaining contradiction be treated as substantive. That discipline makes the article stronger for both sides because it identifies where the record genuinely conflicts and where the conflict is merely semantic.

The fee against the September 2026 discharge ruling#

A management fee is a claim between two entities, and the entities that owed and received this one have now been sorted by a federal court. In Estate of Jeremiah Wright v. County of Stanislaus, E.D. Cal. No. 2:24-cv-02505, order of September 15, 2026, Wellpath LLC — the assignee entitled to the fee after January 2019 — was dismissed as a discharged Chapter 11 debtor, while Wellpath Management, Inc., its predecessor, was not dismissed on the present pleadings, and CFMG, the payor, remained as a nondebtor.

For the eighteen-percent question the consequence is narrow but concrete. Whatever the fee bought — administrative services, infrastructure, or something closer to control — the obligation ran from a nondebtor to a debtor, and the debtor side has now been discharged in at least one California case. If the fee was ever the mechanism by which a management organization extracted value from a professional corporation, the party that extracted it has been released from claims that could have been contemplated before May 9, 2025, while the party that paid it has not. That is not a finding about the fee's lawfulness; it is a fact about who can now be held to account for it, and by whom.

Sources and authorities#

1. H.I.G., 2013 hig.com — https://hig.com/news/h-i-g-capital-announces-strategic-investment-in-california-forensic-medical-group/
2. Medical Board of California — Practice Information www.mbc.ca.gov — https://www.mbc.ca.gov/Licensing/Physicians-and-Surgeons/Practice-Information/